GADD45γ: A new vitamin D-regulated gene that is antiproliferative in prostate cancer cells

Endocrinology

Volumn 151, Issue 10, 2010, Pages 4654-4664

  Flores, Omar ^a   Burnstein, Kerry L ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CALCITRIOL; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; MITOGEN INDUCED GENE 6; MITOGENIC AGENT; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; GADD45G PROTEIN, HUMAN; MIG 6 PROTEIN, HUMAN; MIG-6 PROTEIN, HUMAN; PHARMACOLOGICAL BIOMARKER; SIGNAL PEPTIDE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR SUPPRESSOR PROTEIN; VITAMIN D;

ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN LNCAP; CELLULAR DISTRIBUTION; GENE CONTROL; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; PROTEIN SYNTHESIS; UPREGULATION; CARCINOMA; CLUSTER ANALYSIS; DNA MICROARRAY; DRUG EFFECT; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTINEOPLASTIC AGENTS, HORMONAL; BIOMARKERS, PHARMACOLOGICAL; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; CLUSTER ANALYSIS; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS; TUMOR SUPPRESSOR PROTEINS; VITAMIN D;

EID: 77957259262     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0434     Document Type: Article

References (69)

1. John EM, Schwartz GG, Koo J, Van Den Berg D, Ingles SA 2005 Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer. Cancer Res 65:5470-5479 (Pubitemid 40827360)
2. Schwartz GG, Skinner HG 2007 Vitamin D status and cancer: new insights. Curr Opin Clin Nutr Metab Care 10:6-11 (Pubitemid 44901127)
3. Krishnan AV, Peehl DM, Feldman D 2003 The role of vitamin D in prostate cancer. Recent Results Cancer Res 164:205-221
4. Banerjee P, Chatterjee M 2003 Antiproliferative role of vitamin D and its analogs - a brief overview. Mol Cell Biochem 253:247-254 (Pubitemid 37321732)
5. Stewart LV, Weigel NL 2004 Vitamin D and prostate cancer. Exp Biol Med (Maywood) 229:277-284
6. Deeb KK, Trump DL, Johnson CS 2007 Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 7:684-700
7. Freedman LP 1999 Transcriptional targets of the vitamin D3 receptor- mediating cell cycle arrest and differentiation. J Nutr 129:581S-586S
8. Rachez C, Freedman LP 2000 Mechanisms of gene regulation by vitamin D(3) receptor: a network of coactivator interactions. Gene 246:9-21 (Pubitemid 30190157)
9. Barsony J, Prufer K 2002 Vitamin D receptor and retinoid X receptor interactions in motion. Vitam Horm 65:345-376
10. Moreno J, Krishnan AV, Feldman D 2005 Molecular mechanisms mediating the anti-proliferative effects of Vitamin D in prostate cancer. J Steroid Biochem Mol Biol 97:31-36 (Pubitemid 41546211)
11. Thorne J, Campbell MJ 2008 The vitamin D receptor in cancer. Proc Nutr Soc 67:115-127
12. Revelli A, Massobrio M, Tesarik J 1998 Nongenomic effects of 1α,25-dihydroxyvitamin D(3). Trends Endocrinol Metab 9:419-427
13. Wali RK, Kong J, Sitrin MD, Bissonnette M, Li YC 2003 Vitamin Dreceptor is not required for the rapid actions of 1,25-dihydroxyvitamin D3 to increase intracellular calcium and activate protein kinase C in mouse osteoblasts. J Cell Biochem 88:794-801 (Pubitemid 36258829)
14. Zanello LP, Norman AW 2004 Rapid modulation of osteoblast ion channel responses by 1α,25(OH)2-vitamin D3 requires the presence of a functional vitamin D nuclear receptor. Proc Natl Acad Sci USA 101:1589-1594
15. 1 accumulation. Endocrinology 139:1197-1207
16. Oades GM, Dredge K, Kirby RS, Colston KW 2002 Vitamin D receptor-dependent antitumour effects of 1,25-dihydroxyvitamin D3 and two synthetic analogues in three in vivo models of prostate cancer. BJU Int 90:607-616
17. Banach-Petrosky W, Ouyang X, Gao H, Nader K, Ji Y, Suh N, DiPaola RS, Abate-Shen C 2006 Vitamin D inhibits the formation of prostatic intraepithelial neoplasia in Nkx3.1;Pten mutant mice. Clin Cancer Res 12:5895-5901 (Pubitemid 44629623)
18. Chung I, Han G, Seshadri M, Gillard BM, Yu WD, Foster BA, Trump DL, Johnson CS 2009 Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo. Cancer Res 69:967-975
19. Lokeshwar BL, Schwartz GG, Selzer MG, Burnstein KL, Zhuang SH, Block NL, Binderup L 1999 Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089. Cancer Epidemiol Biomarkers Prev 8:241-248
20. Skowronski RJ, Peehl DM, Feldman D1993 Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines. Endocrinology 132:1952-1960
21. Zhuang SH, Schwartz GG, Cameron D, Burnstein KL 1997 Vitamin D receptor content and transcriptional activity do not fully predict antiproliferative effects of vitamin D in human prostate cancer cell lines. Mol Cell Endocrinol 126:83-90 (Pubitemid 27055550)
22. 1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm. J Biol Chem 278:46862-46868
23. 1 accumulation in C4-2 prostate cancer cells. Endocrinology 150:2046-2054
24. Flores O, Wang Z, Knudsen KE, Burnstein KL 2010 Nuclear targeting of cyclin-dependent kinase 2 reveals essential roles of cyclin-dependent kinase 2 localization and cyclin E in vitamin D-mediated growth inhibition. Endocrinology 151:896-908
25. Takekawa M, Saito H 1998 A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK. Cell 95:521-530
26. Ferby I, Reschke M, Kudlacek O, Knyazev P, Pantè G, Amann K, Sommergruber W, Kraut N, Ullrich A, Fässler R, Klein R 2006 Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation. Nat Med 12:568-573
27. Anastasi S, Baietti MF, Frosi Y, Alemà S, Segatto O 2007 The evolutionarily conserved EBR module of RALT/MIG6 mediates suppression of the EGFR catalytic activity. Oncogene 26:7833-7846
28. Fan W, Richter G, Cereseto A, Beadling C, Smith KA 1999 Cytokine response gene 6 induces p21 and regulates both cell growth and arrest. Oncogene 18:6573-6582
29. Zhang W, Bae I, Krishnaraju K, Azam N, Fan W, Smith K, Hoffman B, Liebermann DA 1999 CR6: a third member in the MyD118 and Gadd45 gene family which functions in negative growth control. Oncogene 18:4899-4907
30. Xu D, Makkinje A, Kyriakis JM 2005 Gene 33 is an endogenous inhibitor of epidermal growth factor (EGF) receptor signaling and mediates dexamethasone-induced suppression of EGF function. J Biol Chem 280:2924-2933
31. Beer TM, Ryan CW, Venner PM, Petrylak DP, Chatta GS, Ruether JD, Redfern CH, Fehrenbacher L, Saleh MN, Waterhouse DM, Carducci MA, Vicario D, Dreicer R, Higano CS, Ahmann FR, Chi KN, Henner WD, Arroyo A, Clow FW, ASCENT Investigators 2007 Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators. J Clin Oncol 25:669-674
32. Lieben L, Benn BS, Ajibade D, Stockmans I, Moermans K, Hediger MA, Peng JB, Christakos S, Bouillon R, Carmeliet G 2010 Trpv6 mediates intestinal calcium absorption during calcium restriction and contributes to bone homeostasis. Bone 47:301-308
33. Zierold C, Mings JA, Prahl JM, Reinholz GG, DeLuca HF 2002 Protein synthesis is required for optimal induction of 25-hydroxyvitamin D(3)-24-hydroxylase, osteocalcin, and osteopontin mRNA by 1,25-dihydroxyvitamin D(3). Arch Biochem Biophys 404:18-24
34. Peng L, Malloy PJ, Feldman D 2004 Identification of a functional vitamin D response element in the human insulin-like growth factor binding protein-3 promoter. Mol Endocrinol 18:1109-1119
35. Krishnan AV, Shinghal R, Raghavachari N, Brooks JD, Peehl DM, Feldman D 2004 Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays. Prostate 59:243-251
36. Akutsu N, Lin R, Bastien Y, Bestawros A, Enepekides DJ, Black MJ, White JH 2001 Regulation of gene Expression by 1α,25-dihydroxyvitamin D3 and Its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells. Mol Endocrinol 15:1127-1139
37. Washington MN, Weigel NL 2010 1α,25-Dihydroxyvitamin D3 inhibits growth of VCaP prostate cancer cells despite inducing the growth-promoting TMPRSS2:ERG gene fusion. Endocrinology 151:1409-1417
38. Moeenrezakhanlou A, Nandan D, Reiner NE 2008 Identification of a calcitriol-regulated Sp-1 site in the promoter of human CD14 using a combined Western blotting electrophoresis mobility shift assay (WEMSA). Biol Proced Online 10:29-35
39. Zhang W, Hoffman B, Liebermann DA 2001 Ectopic expression of MyD118/Gadd45/CR6 (Gadd45β/α/γ) sensitizes neoplastic cells to genotoxic stress-induced apoptosis. Int J Oncol 18:749-757
40. Zhang X, Pickin KA, Bose R, Jura N, Cole PA, Kuriyan J 2007 Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface. Nature 450:741-744
41. Vairapandi M, Balliet AG, Fornace Jr AJ, Hoffman B, Liebermann DA 1996 The differentiation primary response gene MyD118, related to GADD45, encodes for a nuclear protein which interacts with PCNA and p21WAF1/CIP1. Oncogene 12:2579-2594
42. Debes JD, Tindall DJ 2002 The role of androgens and the androgen receptor in prostate cancer. Cancer Lett 187:1-7
43. Feldman BJ, Feldman D 2001 The development of androgen-independent prostate cancer. Nat Rev Cancer 1:34-45
44. Balk SP, Knudsen KE 2008 AR, the cell cycle, and prostate cancer. Nucl Recept Signal 6:e001
45. Jiang F, Wang Z 2004 Gadd45γ is androgen-responsive and growth-inhibitory in prostate cancer cells. Mol Cell Endocrinol 213:121-129 (Pubitemid 38210045)
46. Zhao XY, Ly LH, Peehl DM, Feldman D 1997 1α,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent. Endocrinology 138:3290-3298
47. Beildeck ME, Islam M, Shah S, Welsh J, Byers SW 2009 Control of TCF-4 expression by VDR and vitamin D in the mouse mammary gland and colorectal cancer cell lines. PLoS One 4:e7872
48. Pálmer HG, González-Sancho JM, Espada J, Berciano MT, Puig I, Baulida J, Quintanilla M, Cano A, de Herreros AG, Lafarga M, Muñoz A 2001 Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signaling. J Cell Biol 154:369-387
49. Miyake Z, Takekawa M, Ge Q, Saito H 2007 Activation of MTK1/MEKK4 by GADD45 through induced N-C dissociation and dimerization-mediated trans autophosphorylation of the MTK1 kinase domain. Mol Cell Biol 27:2765-2776
50. Azam N, Vairapandi M, Zhang W, Hoffman B, Liebermann DA 2001 Interaction of CR6 (GADD45γ) with proliferating cell nuclear antigen impedes negative growth control. J Biol Chem 276:2766-2774
51. Ying J, Srivastava G, Hsieh WS, Gao Z, Murray P, Liao SK, Ambinder R, Tao Q 2005 The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors. Clin Cancer Res 11:6442-6449
52. Zhang X, Sun H, Danila DC, Johnson SR, Zhou Y, Swearingen B, Klibanski A 2002 Loss of expression of GADD45γ, a growth inhibitory gene, in human pituitary adenomas: implications for tumorigenesis. J Clin Endocrinol Metab 87:1262-1267
53. Zhang W, Li T, Shao Y, Zhang C, Wu Q, Yang H, Zhang J, Guan M, Yu B, Wan J 2010 Semi-quantitative detection of GADD45-γ methylation levels in gastric, colorectal and pancreatic cancers using methylation-sensitive high-resolution melting analysis. J Cancer Res Clin Oncol 136:1267-1273
54. Mordan-McCombs S, Brown T, Wang WL, Gaupel AC, Welsh J, Tenniswood M 2010 Tumor progression in the LPB-tag transgenic model of prostate cancer is altered by vitamin D receptor and serum testosterone status. J Steroid Biochem Mol Biol 121:368-371
55. Bao BY, Hu YC, Ting HJ, Lee YF 2004 Androgen signaling is required for the vitamin D-mediated growth inhibition in human prostate cancer cells. Oncogene 23:3350-3360
56. Yang ES, Maiorino CA, Roos BA, Knight SR, Burnstein KL 2002 Vitamin D-mediated growth inhibition of an androgen-ablated LNCaP cell line model of human prostate cancer. Mol Cell Endocrinol 186:69-79
57. Armbrecht HJ, Chen ML, Hodam TL, Boltz MA 1997 Induction of 24-hydroxylase cytochrome P450 mRNA by 1,25-dihydroxyvitamin D and phorbol esters in normal rat kidney (NRK-52E) cells. J Endocrinol 153:199-205
58. Lou YR, Nazarova N, Talonpoika R, Tuohimaa P 2005 5α- Dihydrotestosterone inhibits 1α,25-dihydroxyvitamin D3-induced expression of CYP24 in human prostate cancer cells. Prostate 63:222-230
59. 2/M arrest by 1,25-dihydroxyvitamin D3 in ovarian cancer cells mediated through the induction of GADD45 via an exonic enhancer. J Biol Chem 278:48030-48040
60. Zhang YW, Staal B, Su Y, Swiatek P, Zhao P, Cao B, Resau J, Sigler R, Bronson R, Vande Woude GF 2007 Evidence that MIG-6 is a tumor-suppressor gene. Oncogene 26:269-276
61. Hackel PO, Zwick E, Prenzel N, Ullrich A 1999 Epidermal growth factor receptors: critical mediators of multiple receptor pathways. Curr Opin Cell Biol 11:184-189
62. Gioeli D, Mandell JW, Petroni GR, Frierson Jr HF, Weber MJ 1999 Activation of mitogen-activated protein kinase associated with prostate cancer progression. Cancer Res 59:279-284
63. Mehrian-Shai R, Chen CD, Shi T, Horvath S, Nelson SF, Reichardt JK, Sawyers CL 2007 Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancer. Proc Natl Acad Sci USA 104:5563-5568
64. Narvaez CJ, Vanweelden K, Byrne I, Welsh J 1996 Characterization of a vitamin D3-resistant MCF-7 cell line. Endocrinology 137:400-409
65. Narvaez CJ, Byrne BM, Romu S, Valrance M, Welsh J 2003 Induction of apoptosis by 1,25-dihydroxyvitamin D3 in MCF-7 vitamin D3-resistant variant can be sensitized by TPA. J Steroid Biochem Mol Biol 84:199-209
66. 1 accumulation or apoptosis of LNCaP prostate cancer cells. Endocrinology 144:50-60
67. Alagbala AA, Moser MT, Johnson CS, Trump DL, Foster BA 2007 Characterization of vitamin D insensitive prostate cancer cells. J Steroid Biochem Mol Biol 103:712-716
68. Bao BY, Ting HJ, Hsu JW, Yasmin-Karim S, Messing E, Lee YF 2010 Down-regulation of NF-κB signals is involved in loss of 1α,25- dihydroxyvitamin D(3) responsiveness. J Steroid Biochem Mol Biol 120:11-21
69. Zerbini LF, Wang Y, Czibere A, Correa RG, Cho JY, Ijiri K, Wei W, Joseph M, Gu X, Grall F, Goldring MB, Zhou JR, Libermann TA 2004 NF-κB-mediated repression of growth arrest- and DNA-damage- inducible proteins 45α and γ is essential for cancer cell survival. Proc Natl Acad Sci USA 101:13618-13623